Welcome to Innate Pharma

Responding to COVID-19

About Innate Pharma

Innate Pharma S.A. is a commercial stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

See company profile

Headlines

Full Year 2019 Results Conference Call

Innate Pharma held a conference call on 10th March 2020

Access to the replay

Innate Pharma announces publication of IPH4102 Phase I clinical trial results for CTCL in the Lancet Oncology

Publication in The Lancet Oncology of the results from the completed Phase I dose-escalation and expansion clinical trial of IPH4102 in advanced CTCL patients.

See the Press Release and access to the publication